Long-term survival in a patient with primary refractory AML after salvage allogeneic hematopoietic transplantation and post-transplant localized irradiation and venetoclax maintenance: a case report

Overview of attention for article published in Frontiers in oncology, December 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,657 followers.

RT @FrontOncology: New research: Long-term survival in a patient with primary refractory AML after salvage allogeneic hematopoietic transpl…

17 Dec 2023

Reply Repost Favourite

New research: Long-term survival in a patient with primary refractory AML after salvage allogeneic hematopoietic transplantation and post-transplant localized irradiation and venetoclax maintenance: a case report: For patients with primary… https://t.co/MK

16 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.